Horizon Therapeutics 
Welcome,         Profile    Billing    Logout  
 16 Products   292 Diseases   16 Products   28 Trials   668 News 

Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Trials
 022446688110132154176198220
            
            
             
Kineret (anakinra) / SOBI           
          
            
             
Actimmune (interferon gamma-1 b) / Clinigen, Amgen           
          
            
             
Uplizna (inebilizumab-cdon) / Mitsubishi Tanabe, Amgen           
          
            
             
Krystexxa (pegloticase) / Amgen           
          
            
             
Tepezza (teprotumumab-trbw) / Roche, Amgen           
          
            
             
Ravicti (glycerol phenylbutyrate) / Immedica, Amgen           
          
            
             
oxandrolone / Generic mfg.           
          
            
             
Xtoro (finafloxacin) / Amgen           
          
            
             
dazodalibep (HZN-4920) / Amgen           
          
            
             
daxdilimab (HZN-7734) / Amgen           
          
            
             
Procysbi (cysteamine bitartrate delayed release) / Amgen           
          
            
             
DiaPep277 / Evotec, Amgen           
          
            
             
Quinsair (levofloxacin inhalational) / Chiesi, Amgen           
          
            
             
fipaxalparant (AMG 670) / Amgen           
          
            
             
famotidine/ibuprofen / Generic mfg.           
          
            
             
TruNoc (tarenflurbil) / Amgen           
          
            
             
bempikibart (ADX-914) / Q32 Bio           
          
            
             
AMG 329 / Amgen           
          
            
             
bisnorcymserine (ANVS-301) / Annovis Bio           
          
            
             
dasolampanel (NGX-426) / Amgen           
          
            
             
teprotumumab subcutaneous / Xeris Biopharma           
          
            
             
tezampanel (LY-293558) / Proniras Corp